Keyphrases
Amino Acid Residues
33%
Antibacterial Activity
100%
Antimicrobial Activity
33%
Antimicrobial Peptides
33%
Bacterial Load
33%
Bacterial Membrane
33%
Cyclic Peptide
66%
D-amino Acids
33%
Effective Dose
33%
Efficacy in Vivo
33%
Even number
33%
Gram-positive Bacteria
33%
In Vitro Pharmacology
33%
Intravenous Dose
33%
Intravenous Injection
33%
L-peptide
33%
Lethal Concentration
33%
Maximum Permissible Concentration
33%
Membrane Activity
33%
Methicillin-resistant S. Aureus
100%
Multidrug-resistant Infection
33%
Multiple Components
33%
Neutropenic Mouse
33%
Organic Nanotube
33%
Peritonitis
66%
Pharmacokinetic Profile
33%
Prolonged Exposure
33%
Protease Treatment
33%
Spontaneous Resistance
33%
Staphylococcus Aureus
66%
Structure-activity Relationship Studies
33%
Synthetic Cyclic Peptide
100%
Systemic Administration
33%
Systemic Treatment
33%
Therapeutic Properties
33%
Therapeutic Window
33%
Thigh Infection Model
66%
Volume of Distribution at Steady State
33%
Pharmacology, Toxicology and Pharmaceutical Science
Amino Acid
20%
Antibacterial Activity
100%
Antimicrobial Agent
20%
Cyclopeptide
100%
Gram Positive Bacterium
20%
Infection
60%
Long Term Exposure
20%
Meticillin
60%
Nanotube
20%
Peritonitis
40%
Pharmacokinetics
20%
Polypeptide Antibiotic Agent
20%
Proteinase
20%
Staphylococcus Aureus
100%
Structure Activity Relationship
20%
Systemic Administration
20%
Therapeutic Window
20%
Volume of Distribution
20%
Immunology and Microbiology
Amino Acid
20%
Antibacterial Activity
100%
Antimicrobial Activity
20%
Antimicrobial Agent
20%
Antimicrobial Peptides
20%
Bacterial Load
20%
Bacterial Membrane
20%
Cyclic Peptide
100%
Gram-Positive Bacteria
20%
Minimum Inhibitory Concentration
20%
Peptides
100%
Peritonitis
40%
Pharmacokinetics
20%
Staphylococcus Aureus
100%
Steady State
20%
Structure Activity Relation
20%